Squarepoint’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

Squarepoint’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-357	Closed	-$22.7K	–	5014
2024 Q4	$22.7K	Sell	357 -14	-4%	-$841	﹤0.01%	4926
2024 Q3	$22.2K	Buy	+371	New	+$22.9K	﹤0.01%	4016

Other funds holding IXHL

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Squarepoint's IXHL Position: Q1 2025 in Review

Squarepoint sold out of Incannex Healthcare Limited Common Stock (IXHL) in Q1 2025, closing a stake of 357 shares — an estimated $22.7K sold.

Squarepoint first reported a position in IXHL in Q3 2024 and held it in 2 quarters. The position peaked at $22.7K in Q4 2024. 6 funds tracked by Wall St. Rank hold IXHL as of Q1 2025.

Squarepoint reported no remaining Incannex Healthcare Limited Common Stock position as of Q1 2025 after selling out during the quarter.
Squarepoint sold 357 Incannex Healthcare Limited Common Stock shares in Q1 2025, an estimated $22.7K.
Squarepoint first reported a position in Incannex Healthcare Limited Common Stock in Q3 2024 and held it in 2 quarters.
Squarepoint's Incannex Healthcare Limited Common Stock position peaked at $22.7K in Q4 2024.
6 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.